Abdominal SurgeriesNCT07855328
Enhanced Recovery After Surgery (ERAS) Protocols on Postoperative Outcomes in Patients Undergoing Major Abdominal Procedures
A study testing ERAS in people with Abdominal Surgeries, run by Dr Mudassar Saeed Pansota.
Trial summary
ERAS protocols are still only partially and unevenly implemented in many hospitals in developing nations, despite substantial worldwide evidence to the contrary. Because of institutional regulations, lack of understanding, or budget constraints, local surgical units frequently stick to traditional perioperative care… Read more about this study
- Who is it for?
- Ages 18 to 70 years
- Conditions the study is for
- Abdominal Surgeries
- What is being tested?
- ERAS
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 166 participants
- Where
- No sites listed yet
- Study dates
- 1 Oct 2026to 31 Jan 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients of either gender between the ages of 18 and 70 years.
- Individuals having elective major abdominal surgery (such as small bowel resection, right hemicolectomy, left hemicolectomy, sigmoid colectomy, anterior resection, or similar colorectal resection).
- ASA class I-III patients
Who cannot join
- Patients who need to stay in the intensive care unit (ICU) after surgery for more than twenty-four hours.
- Individuals suffering from significant organ malfunction, such as advanced heart, liver, or kidney failure.
- Individuals who have had significant abdominal surgery within the recent three months.
- Patients who withdraw their consent or decline to participate in the study
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Impact of Enhanced Recovery After Surgery (ERAS) Protocols on Postoperative Outcomes in Patients Undergoing Major Abdominal Procedures
ERAS protocols are still only partially and unevenly implemented in many hospitals in developing nations, despite substantial worldwide evidence to the contrary. Because of institutional regulations, lack of understanding, or budget constraints, local surgical units frequently stick to traditional perioperative care approaches. Furthermore, there is a dearth of local data assessing the viability and efficacy of ERAS protocols in patients undergoing significant abdominal surgeries in our healthcare settings. Thus, the purpose of this study is to evaluate how ERAS protocols affect the postoperative results of patients having major abdominal surgery at our facility. The study's findings will be useful in determining whether ERAS pathways will assist our patient population heal more quickly, experience fewer issues, and spend less time in the hospital. The results might potentially encourage the use of standardized ERAS procedures in surgical practice, which would enhance patient care and maximize the use of medical resources
Read the detailed description
Significant postoperative morbidity, extended hospital stays, delayed recovery, and higher healthcare expenditures are linked to major abdominal surgeries, including colorectal, hepatobiliary, and gastric procedures. Prolonged fasting, copious IV fluids, delayed mobilization, and delayed oral meals are common components of traditional perioperative care, which may raise physiological stress and hinder surgical recovery. Enhanced Recovery After Surgery (ERAS) guidelines have become a contemporary perioperative care strategy in recent years, with the goal of improving surgical outcomes and speeding recovery after major procedures.
In order to reduce surgical stress, maintain physiological function, and encourage early postoperative recovery, ERAS is a multidisciplinary, evidence-based treatment route that incorporates a number of perioperative techniques. Preoperative counseling, reduced fasting with carbohydrate loading, less invasive surgical procedures, multimodal analgesia, early mobilization, early oral feeding introduction, and other coordinated preoperative, intraoperative, and postoperative therapies are all part of these protocols. ERAS protocols have been extensively used in various surgical specialties over the last ten years, especially in colorectal and other significant abdominal procedures. When compared to traditional perioperative treatment, a number of recent research and systematic reviews have shown that ERAS approaches considerably improve postoperative outcomes. Without raising readmission or death rates, ERAS implementation has been linked to fewer postoperative complications, an earlier recovery of bowel function, a shorter hospital stay, and lower healthcare costs
- Conditions
- Abdominal Surgeries
- Being tested
- ERAS, Standard Care (in control arm)
- Keywords
- abdominal surgeries, ERAS, outcome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ERASProcedure or surgery
Patients managed by the surgical team according to the ERAS pathway will be included in Group A (ERAS group)
Standard Care (in control arm)Procedure or surgery
Patients managed according to routine conventional perioperative care during the study period will be included in Group B (conventional care group)
| Study group | Role | What they receive |
|---|---|---|
| ERAS | Experimental | Not described Receives: Procedure: ERAS |
| Standard care | Placebo comparator | Not described Receives: Procedure: Standard Care (in control arm) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Rate of Postoperative Complications
Surgical site infection: superficial, deep, or organ-space infection diagnosed clinically by the treating surgeon or supported by wound findings, culture results, imaging, or the need for antibiotics or drainage. Anastomotic leak: clinical or radiological evidence of leakage from a surgical anastomosis, including feculent discharge from drain or wound, intra-abdominal collection related to anastomosis, or leak confirmed on imaging or reoperation. Ileus: failure of return of bowel function requiring continued nil per oral status, nasogastric decompression, or delayed oral intake beyond routine postoperative recovery as documented by the surgical team). As recorded in the patient's medical file, complications will be found by radiological results, laboratory tests, and clinical examinations
Measured: 30 days
Mean hospital stay
described as the total number of days between the day of surgery and the day of hospital discharge. For every patient, it will be computed in days and documented
Measured: 1 week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Oct 2026
- Study start1 Oct 2026 (estimated)
- Primary completion31 Dec 2026 (estimated)
- Study completion31 Jan 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Abdominal SurgeriesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 166 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Dr Mudassar Saeed Pansota
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Dr Mudassar Saeed Pansota, Shahida Islam Medical Complex
- Investigators
- muhammad ali armughan, MBBS, Principal investigator, Allama Iqbal Teaching Hospital, DG Khan
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07855328
- Sponsor's protocol ID
- Allama Iqbal Teaching Hospital
- Status last verified
- Sep 2026
- First submitted
- 27 Sep 2026
- Last updated
- 2 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 2 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact of Enhanced Recovery After Surgery (ERAS) Protocols on Postoperative Outcomes in Patients Undergoing Major Abdominal Procedures
- ClinicalTrials.gov ID
- NCT07855328
- Acronym / sponsor ID
- Allama Iqbal Teaching Hospital
- Conditions
- Abdominal Surgeries
- Keywords
- abdominal surgeries, ERAS, outcome
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 166 participants (estimated)
- Lead sponsor
- Dr Mudassar Saeed PansotaUniversity, hospital or other
- Study start
- 1 Oct 2026 (estimated)
- Primary completion
- 31 Dec 2026 (estimated)
- Study completion
- 31 Jan 2027 (estimated)
- First posted
- 2 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
ERAS protocols are still only partially and unevenly implemented in many hospitals in developing nations, despite substantial worldwide evidence to the contrary. Because of institutional regulations, lack of understanding, or budget constraints, local surgical units frequently stick to traditional perioperative care approaches. Furthermore, there is a dearth of local data assessing the viability and efficacy of ERAS protocols in patients undergoing significant abdominal surgeries in our healthcare settings. Thus, the purpose of this study is to evaluate how ERAS protocols affect the postoperative results of patients having major abdominal surgery at our facility. The study's findings will be useful in determining whether ERAS pathways will assist our patient population heal more quickly, experience fewer issues, and spend less time in the hospital. The results might potentially encourage the use of standardized ERAS procedures in surgical practice, which would enhance patient care and maximize the use of medical resources
Detailed description
Significant postoperative morbidity, extended hospital stays, delayed recovery, and higher healthcare expenditures are linked to major abdominal surgeries, including colorectal, hepatobiliary, and gastric procedures. Prolonged fasting, copious IV fluids, delayed mobilization, and delayed oral meals are common components of traditional perioperative care, which may raise physiological stress and hinder surgical recovery. Enhanced Recovery After Surgery (ERAS) guidelines have become a contemporary perioperative care strategy in recent years, with the goal of improving surgical outcomes and speeding recovery after major procedures.
In order to reduce surgical stress, maintain physiological function, and encourage early postoperative recovery, ERAS is a multidisciplinary, evidence-based treatment route that incorporates a number of perioperative techniques. Preoperative counseling, reduced fasting with carbohydrate loading, less invasive surgical procedures, multimodal analgesia, early mobilization, early oral feeding introduction, and other coordinated preoperative, intraoperative, and postoperative therapies are all part of these protocols. ERAS protocols have been extensively used in various surgical specialties over the last ten years, especially in colorectal and other significant abdominal procedures. When compared to traditional perioperative treatment, a number of recent research and systematic reviews have shown that ERAS approaches considerably improve postoperative outcomes. Without raising readmission or death rates, ERAS implementation has been linked to fewer postoperative complications, an earlier recovery of bowel function, a shorter hospital stay, and lower healthcare costs
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| ERAS | Experimental | Procedure: ERAS |
| Standard care | Placebo comparator | Procedure: Standard Care (in control arm) |
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Patients of either gender between the ages of 18 and 70 years.
- Individuals having elective major abdominal surgery (such as small bowel resection, right hemicolectomy, left hemicolectomy, sigmoid colectomy, anterior resection, or similar colorectal resection).
- ASA class I-III patients
Key exclusion criteria (4 listed)
- Patients who need to stay in the intensive care unit (ICU) after surgery for more than twenty-four hours.
- Individuals suffering from significant organ malfunction, such as advanced heart, liver, or kidney failure.
- Individuals who have had significant abdominal surgery within the recent three months.
- Patients who withdraw their consent or decline to participate in the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ERASPatients managed by the surgical team according to the ERAS pathway will be included in Group A (ERAS group) | Procedure or surgery | ERAS |
| Standard Care (in control arm)Patients managed according to routine conventional perioperative care during the study period will be included in Group B (conventional care group) | Procedure or surgery | Standard care |
Primary outcome
Rate of Postoperative Complications
Time frame: 30 days
Surgical site infection: superficial, deep, or organ-space infection diagnosed clinically by the treating surgeon or supported by wound findings, culture results, imaging, or the need for antibiotics or drainage. Anastomotic leak: clinical or radiological evidence of leakage from a surgical anastomosis, including feculent discharge from drain or wound, intra-abdominal collection related to anastomosis, or leak confirmed on imaging or reoperation. Ileus: failure of return of bowel function requiring continued nil per oral status, nasogastric decompression, or delayed oral intake beyond routine postoperative recovery as documented by the surgical team). As recorded in the patient's medical file, complications will be found by radiological results, laboratory tests, and clinical examinations
Mean hospital stay
Time frame: 1 week
described as the total number of days between the day of surgery and the day of hospital discharge. For every patient, it will be computed in days and documented
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Oct 2026.
Related trials for Abdominal Surgeries
Active, not recruiting
Influence of FreeO2 on Percentage of Time Within Oxygen Saturation Target Using Noninvasive Ventilation (NIV) and Continuous Positive Airway Pressure (CPAP) for Patients Admitted for AECOPD or Bariatric Surgery
COPD Exacerbation, Oxygen Toxicity
Recruiting
Management of Abdominal Post-surgical Scar With Ozoaqua Versus Standard Care
Wound Healing, Abdominal Surgery
Recruiting
Implementation of a Pain Management Plan in Major Open Abdominal Surgeries.
Abdomen Cancer, Pancreas Adenocarcinoma (MSI-H)
Not yet recruiting
Effect of Baduanjin Exercise on Pain, Fatigue, and Quality of Recovery After Abdominal Surgery
Abdominal Surgery, Baduanjin
Enrolling by invitationObservational study
Intestinal Obstruction Surgery. Acute Abdominal Pathology. №9:05/05/2026
Small Bowel Adhesion, Obstruction Bowel
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
muhammad ali armughan, MBBS principal investigator
Allama Iqbal Teaching Hospital, DG Khan
Questions about this trial
What is this clinical trial studying?
A study testing ERAS in people with Abdominal Surgeries, run by Dr Mudassar Saeed Pansota.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 2 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Muhammad Ali Armughan, MBBS (03337950197, armughan915@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Rate of Postoperative Complications (time frame: 30 days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2026; AzTrials last refreshed its copy on 6 Nov 2026.